The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.

Bergeron J, Capo-Chichi JM, Tsui H, Mahe E, Berardi P, Minden MD, Brandwein JM, Schuh AC

Open source

DOI
10.3390/curroncol30120759
Published
2023 Dec 12
Container
Current oncology (Toronto, Ont.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol30120759,
  title = {The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.},
  author = {Bergeron J and Capo-Chichi JM and Tsui H and Mahe E and Berardi P and Minden MD and Brandwein JM and Schuh AC},
  year = {2023},
  journal = {Current oncology (Toronto, Ont.)},
  doi = {10.3390/curroncol30120759},
  url = {https://doi.org/10.3390/curroncol30120759}
}

RIS

TY  - JOUR
TI  - The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.
AU  - Bergeron J
AU  - Capo-Chichi JM
AU  - Tsui H
AU  - Mahe E
AU  - Berardi P
AU  - Minden MD
AU  - Brandwein JM
AU  - Schuh AC
PY  - 2023
JO  - Current oncology (Toronto, Ont.)
DO  - 10.3390/curroncol30120759
UR  - https://doi.org/10.3390/curroncol30120759
ER  - 

APA

J, B., JM, C., H, T., E, M., P, B., MD, M., JM, B., & AC, S. (2023). The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol30120759

Source records